Merck | MRK - Net Income

Stock Price
109.50
Daily Change
-2.40 -2.14%
Monthly
1.96%
Yearly
-10.76%
Q2 Forecast
108.96

Merck reported EUR319M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Adidas EUR 81M 380M Dec/2025
Adyen EUR 480.96M 34.59M Jun/2025
Akzo Nobel EUR 93M 505M Mar/2026
Alcon AG USD 217M 20M Dec/2025
Amadeus IT EUR 247.5M 113.3M Dec/2025
Amarin USD -1.22M 6.51M Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
BASF EUR 560M 388M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Beiersdorf EUR 387M 165M Dec/2025
Covestro EUR -378M 331M Dec/2025
Danone EUR 778M 260M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 327M 52.2M Dec/2025
Galapagos EUR 782.15M 984.26M Dec/2025
Genmab DKK 31M 370M Dec/2025
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 98.25M 28.72M Dec/2025
Henkel EUR 925M 185M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Infineon EUR 256M 29M Dec/2025
Linde USD 1.53B 399M Dec/2025
Lonza CHF 426M 119M Jun/2025
Merck EUR 319M 583M Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Philips EUR 395M 211M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
UCB EUR 1.08B 608M Dec/2025